<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Filliol A</submitter><funding>NIDDK NIH HHS</funding><funding>Medical Research Council</funding><funding>NCI NIH HHS</funding><funding>Wellcome Trust</funding><funding>NIH HHS</funding><pagination>356-365</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9949942</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>610(7931)</volume><pubmed_abstract>Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide, develops almost exclusively in patients with chronic liver disease and advanced fibrosis&lt;sup>1,2&lt;/sup>. Here we interrogated functions of hepatic stellate cells (HSCs), the main source of liver fibroblasts&lt;sup>3&lt;/sup>, during hepatocarcinogenesis. Genetic depletion, activation or inhibition of HSCs in mouse models of HCC revealed their overall tumour-promoting role. HSCs were enriched in the preneoplastic environment, where they closely interacted with hepatocytes and modulated hepatocarcinogenesis by regulating hepatocyte proliferation and death. Analyses of mouse and human HSC subpopulations by single-cell RNA sequencing together with genetic ablation of subpopulation-enriched mediators revealed dual </pubmed_abstract><journal>Nature</journal><pubmed_title>Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.</pubmed_title><pmcid>PMC9949942</pmcid><funding_grant_id>219542/Z/19/Z</funding_grant_id><funding_grant_id>R01 DK116620</funding_grant_id><funding_grant_id>U01 CA274295</funding_grant_id><funding_grant_id>F31 DK091980</funding_grant_id><funding_grant_id>R01 CA233794</funding_grant_id><funding_grant_id>P30 DK132710</funding_grant_id><funding_grant_id>R01 CA234128</funding_grant_id><funding_grant_id>R01 CA211794</funding_grant_id><funding_grant_id>P30 CA013696</funding_grant_id><funding_grant_id>S10 OD020056</funding_grant_id><funding_grant_id>R37 CA258829</funding_grant_id><funding_grant_id>R01 DK128955</funding_grant_id><funding_grant_id>R01 CA228483</funding_grant_id><funding_grant_id>R01 CA262424</funding_grant_id><funding_grant_id>R01 CA190844</funding_grant_id><funding_grant_id>R21 CA263381</funding_grant_id><pubmed_authors>Dobie R</pubmed_authors><pubmed_authors>Savage TM</pubmed_authors><pubmed_authors>Caviglia JM</pubmed_authors><pubmed_authors>Saito Y</pubmed_authors><pubmed_authors>Dapito DH</pubmed_authors><pubmed_authors>Wallace S</pubmed_authors><pubmed_authors>Ravichandra A</pubmed_authors><pubmed_authors>Caruso S</pubmed_authors><pubmed_authors>Su H</pubmed_authors><pubmed_authors>Friedman RA</pubmed_authors><pubmed_authors>Arpaia N</pubmed_authors><pubmed_authors>Izar B</pubmed_authors><pubmed_authors>Sun Q</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Rodriguez-Fiallos OM</pubmed_authors><pubmed_authors>Filliol A</pubmed_authors><pubmed_authors>Amin AD</pubmed_authors><pubmed_authors>Bhattacharjee S</pubmed_authors><pubmed_authors>Hoshida Y</pubmed_authors><pubmed_authors>Kang JK</pubmed_authors><pubmed_authors>Henderson NC</pubmed_authors><pubmed_authors>Chin L</pubmed_authors><pubmed_authors>Zucman-Rossi J</pubmed_authors><pubmed_authors>Yu LX</pubmed_authors><pubmed_authors>Chen D</pubmed_authors><pubmed_authors>Pajvani UB</pubmed_authors><pubmed_authors>Wilson-Kanamori JR</pubmed_authors><pubmed_authors>Schwabe RF</pubmed_authors><pubmed_authors>Tabas I</pubmed_authors><pubmed_authors>Yin D</pubmed_authors><pubmed_authors>Fujiwara N</pubmed_authors><pubmed_authors>Yin C</pubmed_authors><pubmed_authors>Remotti HE</pubmed_authors><pubmed_authors>Affo S</pubmed_authors><pubmed_authors>Mehal A</pubmed_authors><pubmed_authors>Wells RG</pubmed_authors><pubmed_authors>Nair A</pubmed_authors><pubmed_authors>Karin M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.</name><description>Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide, develops almost exclusively in patients with chronic liver disease and advanced fibrosis&lt;sup>1,2&lt;/sup>. Here we interrogated functions of hepatic stellate cells (HSCs), the main source of liver fibroblasts&lt;sup>3&lt;/sup>, during hepatocarcinogenesis. Genetic depletion, activation or inhibition of HSCs in mouse models of HCC revealed their overall tumour-promoting role. HSCs were enriched in the preneoplastic environment, where they closely interacted with hepatocytes and modulated hepatocarcinogenesis by regulating hepatocyte proliferation and death. Analyses of mouse and human HSC subpopulations by single-cell RNA sequencing together with genetic ablation of subpopulation-enriched mediators revealed dual </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-05-28T22:52:22.083Z</modification><creation>2025-02-19T04:20:45.746Z</creation></dates><accession>S-EPMC9949942</accession><cross_references><pubmed>36198802</pubmed><doi>10.1038/s41586-022-05289-6</doi></cross_references></HashMap>